Systemic G-CSF treatment does not improve long-term outcomes after neonatal hypoxic-ischaemic brain injury

Experimental Neurology

Volumn 230, Issue 1, 2011, Pages 67-74

  Schlager, G W ^a   Griesmaier, E ^b   Wegleiter, K ^b   Neubauer, V ^b   Urbanek, M ^b   Kiechl Kohlendorfer, U ^b   Felderhoff Mueser, U ^a   Keller, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

G CSF; Hypoxia ischaemia; Newborns

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; HISTOPATHOLOGY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN FIELD TEST; PERINATAL PERIOD; PRIORITY JOURNAL; RECOGNITION; ROTAROD TEST;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HYPOXIA-ISCHEMIA, BRAIN; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECOGNITION (PSYCHOLOGY); RNA, MESSENGER; ROTAROD PERFORMANCE TEST; TIME FACTORS;

EID: 79958045173     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.11.021     Document Type: Article

References (66)

1. Allin M., Walshe M., Fern A., Nosarti C., Cuddy M., Rifkin L., Murray R., Rushe T., Wyatt J. Cognitive maturation in preterm and term born adolescents. J. Neurol. Neurosurg. Psychiatry 2008, 79:381-386.
2. Anand K.J., Scalzo F.M. Can adverse neonatal experiences alter brain development and subsequent behavior?. Biol. Neonate 2000, 77:69-82.
3. Anand K.J.S., Garg S., Rovnaghi C.R., Narsinghani U., Bhutta A.T., Hall R.W. Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatr. Res. 2007, 62:283-290.
4. Angeles D.M., Wycliffe N., Michelson D., Holshouser B.A., Deming D.D., Pearce W.J., Sowers L.C., Ashwal S. Use of opioids in asphyxiated term neonates: effects on neuroimaging and clinical outcome. Pediatr. Res. 2005, 57:873-878.
5. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86:159-171.
6. Bath P.M.W., Sprigg N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst. Rev. 2007, CD005207.
7. Bayless S., Stevenson J. Executive functions in school-age children born very prematurely. Early Hum. Dev. 2007, 83:247-254.
8. Bevins R.A., Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat. Protoc. 2006, 1:1306-1311.
9. Bodine D.M., Seidel N.E., Gale M.S., Nienhuis A.W., Orlic D. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994, 84:1482-1491.
10. Bridell R.A., Hartley C.A., Smith K.A., McNiece I.K. Recombinant rat stem cell factor synergizes with recombinant human granulocyte-colony stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating ability. Blood 1993, 82:1720-1723.
11. Carr R., Modi N., Doré C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst. Rev. 2003, CD003066.
12. Chevalier G., Deniau J.M. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci. 1990, 13:277-280.
13. Comi A.M., Johnston M.V., Wilson M.A. Strain variability, injury distribution, and seizure onset in a mouse model of stroke in the immature brain. Dev. Neurosci. 2005, 27:127-133.
14. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr. Res. 1997, 42:1-8.
15. Doetsch F. A niche for adult neural stem cells. Curr. Opin. Genet. Dev. 2003, 13:543-550.
16. Donini M., Fontana S., Savoldi G., Vermi W., Tassone L., Gentili F., Zenaro E., Ferrari D., Notarangelo L.D., Porta F., Facchetti F., Notarangelo L.D., Dusi S., Badolato R. G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms. Blood 2007, 109:4716-4723.
17. England T.J., Gibson C.L., Bath P.M.W. Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: a systematic review. Brain Res. Rev. 2009, 62:71-82.
18. Ennaceur A., Michalikova S., Bradford A., Ahmed S. Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks. Behav. Brain Res. 2005, 159:247-266.
19. Ergorul C., Eichenbaum H. The hippocampus and memory for "what," "where," and "when". Learn. Mem. 2004, 11:397-405.
20. Felderhoff-Mueser U., Bittigau P., Sifringer M., Jarosz B., Korobowicz E., Mahler L., Piening T., Moysich A., Grune T., Thor F., Heumann R., Bührer C., Ikonomidou C. Oxygen causes cell death in the developing brain. Neurobiol. Dis. 2004, 17:273-282.
21. Gerstner B., DeSilva T.M., Genz K., Armstrong A., Brehmer F., Neve R.L., Felderhoff-Mueser U., Volpe J.J., Rosenberg P.A. Hyperoxia causes maturation-dependent cell death in the developing white matter. J. Neurosci. 2008, 28:1236-1245.
22. Gibson C.L., Jones N.C., Prior M.J.W., Bath P.M.W., Murphy S.P. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 2005, 64:763-769.
23. Gibson C.L., Bath P.M.W., Murphy S.P. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2005, 25:431-439.
24. Hagberg H., Wilson M.A., Matsushita H., Zhu C., Lange M., Gustavsson M., Poitras M.F., Dawson T.M., Dawson V.L., Northington F., Johnston M.V. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J. Neurochem. 2004, 90:1068-1075.
25. Hasselblatt M., Jeibmann A., Riesmeier B., Maintz D., Schäbitz W.-R. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol. 2007, 113:45-51.
26. Keller M., Simbruner G., Górna A., Urbanek M., Tinhofer I., Griesmaier E., Sarkozy G., Schwendimann L., Gressens P. Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice. Pediatr. Res. 2006, 59:549-553.
27. Kim B.R., Shim J.W., Sung D.K., Kim S.S., Jeon G.W., Kim M.J., Chang Y.S., Park W.S., Choi E.S. Granulocyte stimulating factor attenuates hypoxic-ischemic brain injury by inhibiting apoptosis in neonatal rats. Yonsei Med. J. 2008, 49:836-842.
28. Kobaly K., Schluchter M., Minich N., Friedman H., Taylor H.G., Wilson-Costello D., Hack M. Outcomes of extremely low birth weight (<1kg) and extremely low gestational age (<28weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003. Pediatrics 2008, 121:73-81.
29. Kuhn P., Messer J., Paupe A., Espagne S., Kacet N., Mouchnino G., Klosowski S., Krim G., Lescure S., Bouedec S.L., Meyer P., Astruc D. A multicenter, randomized, placebo-controlled trial of prophylactic recombinant granulocyte-colony stimulating factor in preterm neonates with neutropenia. J. Pediatr. 2009, 155:324-330.
30. Larroque B., Ancel P.-Y., Marret S., Marchand L., André M., Arnaud C., Pierrat V., Rozé J.-C., Messer J., Thiriez G., Burguet A., Picaud J.-C., Bréart G., Kaminski M. Neurodevelopmental disabilities and special care of 5-year-old children born before 33weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 2008, 371:813-820. group, E.P.I.P.A.G.E.S.
31. Lee S.-T., Chu K., Jung K.-H., Ko S.-Y., Kim E.-H., Sinn D.I., Lee Y.S., Lo E.H., Kim M., Roh J.K. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 2005, 1058:120-128.
32. Lindström K., Lagerroos P., Gillberg C., Fernell E. Teenage outcome after being born at term with moderate neonatal encephalopathy. Pediatr. Neurol. 2006, 35:268-274.
33. Marlow N., Rose A.S., Rands C.E., Draper E.S. Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Arch. Dis. Child. Fetal Neonatal Ed. 2005, 90:F380-F387.
34. McPherson R.J., Mascher-Denen M., Juul S.E. Postnatal stress produces hyperglycemia in adult rats exposed to hypoxia-ischemia. Pediatr. Res. 2009, 66:278-282.
35. Mestan K.K.L., Marks J.D., Hecox K., Huo D., Schreiber M.D. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N. Engl. J. Med. 2005, 353:23-32.
36. Moster D., Lie R.T., Markestad T. Joint association of Apgar scores and early neonatal symptoms with minor disabilities at school age. Arch. Dis. Child. Fetal Neonatal Ed. 2002, 86:F16-F21.
37. Peterson B.S., Vohr B., Staib L.H., Cannistraci C.J., Dolberg A., Schneider K.C., Katz K.H., Westerveld M., Sparrow S., Anderson A.W., Duncan C.C., Makuch R.W., Gore J.C., Ment L.R. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA 2000, 284:1939-1947.
38. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
39. Platt M.J., Cans C., Johnson A., Surman G., Topp M., Torrioli M.G., Krageloh-Mann I. Trends in cerebral palsy among infants of very low birthweight (<1500g) or born prematurely (<32weeks) in 16 European centres: a database study. Lancet 2007, 369:43-50.
40. R Development Core Team R: a Language and Environment for Statistical Computing 2003, R Foundation for Statistical Computing, Vienna, Austria.
41. Robertson C.M., Finer N.N. Educational readiness of survivors of neonatal encephalopathy associated with birth asphyxia at term. J. Dev. Behav. Pediatr. 1988, 9:298-306.
42. Rovnaghi C.R., Garg S., Hall R.W., Bhutta A.T., Anand K.J. Ketamine analgesia for inflammatory pain in neonatal rats: a factorial randomized trial examining long-term effects. Behav. Brain Funct. 2008, 4:35.
43. Rozas G., Guerra M.J., Labandeira-Garcìa J.L. An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res. Brain Res. Protoc. 1997, 2:75-84.
44. Ruijter J.M., Ramakers C., Hoogaars W.M.H., Karlen Y., Bakker O., van den Hoff M.J.B., Moorman A.F.M. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009, 37:e45.
45. Rustay N.R., Wahlsten D., Crabbe J.C. Assessment of genetic susceptibility to ethanol intoxication in mice. Proc. Natl Acad. Sci. USA 2003, 100:2917-2922.
46. Schäbitz W.-R., Schneider A. Developing granulocyte-colony stimulating factor for the treatment of stroke: current status of clinical trials. Stroke 2006, 37:1654. author reply 1655.
47. Schäbitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Schölzke M.N., Sommer C., Schwab S. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003, 34:745-751.
48. Sheldon R.A., Sedik C., Ferriero D.M. Strain-related brain injury in neonatal mice subjected to hypoxia-ischemia. Brain Res. 1998, 810:114-122.
49. Schneider A., Krüger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.-G., Schäbitz W.-R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 2005, 115:2083-2098.
50. Shyu W.-C., Lin S.-Z., Yang H.-I., Tzeng Y.-S., Pang C.-Y., Yen P.-S., Li H. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004, 110:1847-1854.
51. Shyu W.-C., Lin S.-Z., Lee C.-C., Liu D.D., Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 2006, 174:927-933.
52. Six I., Gasan G., Mura E., Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur. J. Pharmacol. 2003, 458:327-328.
53. Sutcliffe J.S., Marshall K.M., Neill J.C. Influence of gender on working and spatial memory in the novel object recognition task in the rat. Behav. Brain Res. 2007, 177:117-125.
54. Suzuki W.A., Zola-Morgan S., Squire L.R., Amaral D.G. Lesions of the perirhinal and parahippocampal cortices in the monkey produce long-lasting memory impairment in the visual and tactual modalities. J. Neurosci. 1993, 13:2430-2451.
55. Taguchi A., Wen Z., Myojin K., Yoshihara T., Nakagomi T., Nakayama D., Tanaka H., Soma T., Stern D.M., Naritomi H., Matsuyama T. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model. Eur. J. Neurosci. 2007, 26:126-133.
56. Talebian L., Li Z., Guo Y., Gaudet J., Speck M.E., Sugiyama D., Kaur P., Pear W.S., Maillard I., Speck N.A. T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage. Blood 2007, 109:11-21.
57. Thoresen M., Satas S., Løberg E.M., Whitelaw A., Acolet D., Lindgren C., Penrice J., Robertson N., Haug E., Steen P.A. Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not neuroprotective. Pediatr. Res. 2001, 50:405-411.
58. Tooley J.R., Satas S., Porter H., Silver I.A., Thoresen M. Head cooling with mild systemic hypothermia in anesthetized piglets is neuroprotective. Ann. Neurol. 2003, 53:65-72.
59. van der Kooij M.A., Ohl F., Arndt S.S., Kavelaars A., van Bel F., Heijnen C.J. Mild neonatal hypoxia-ischemia induces long-term motor- and cognitive impairments in mice. Brain Behav Immun. 2010, 24(5):850-856. Epub 2009 Sep 11. PubMed PMID: 19748566.
60. Vannucci R.C., Vannucci S.J. A model of perinatal hypoxic-ischemic brain damage. Ann. NY Acad. Sci. 1997, 835:234-249.
61. Vaupel D.B., McCoun D., Cone E.J. Phencyclidine analogs and precursors: rotarod and lethal dose studies in the mouse. J. Pharmacol. Exp. Ther. 1984, 230:20-27.
62. Vohr B.R., Wright L.L., Dusick A.M., Mele L., Verter J., Steichen J.J., Simon N.P., Wilson D.C., Broyles S., Bauer C.R., Delaney-Black V., Yolton K.A., Fleisher B.E., Papile L.A., Kaplan M.D. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000, 105:1216-1226.
63. Whimbey A.E., Denenberg V.H. Two independent behavioral dimensions in open-field performance. J. Comp. Physiol. Psychol. 1967, 63:500-504.
64. Woodward L.J., Edgin J.O., Thompson D., Inder T.E. Object working memory deficits predicted by early brain injury and development in the preterm infant. Brain 2005, 128:2578-2587.
65. Yata K., Matchett G.A., Tsubokawa T., Tang J., Kanamaru K., Zhang J.H. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res. 2007, 1145:227-238.
66. Zhu C., Wang X., Xu F., Bahr B.A., Shibata M., Uchiyama Y., Hagberg H., Blomgren K. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ. 2005, 12:162-176.